TransCode Therapeutics Announces Initial Dosing in Fourth Cohort of Phase 1 Clinical Trial with TTX-MC138 ...Middle East

First patient in Cohort four has been treated with TTX-MC138 Ten patients have been treated with TTX-MC138 at escalating dose levels Additional patients being evaluated for eligibility for expanded enrollment No significant safety or dose limiting toxicities have been reported BOSTON,...

Hence then, the article about transcode therapeutics announces initial dosing in fourth cohort of phase 1 clinical trial with ttx mc138 was published today ( Thursday 27/03/2025 - 11:41 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( TransCode Therapeutics Announces Initial Dosing in Fourth Cohort of Phase 1 Clinical Trial with TTX-MC138 )

Also on site :

• Human heads displayed at Ecuador tourist beach in warning to gangs
• What To Watch Sunday: The Night Manager And Industry Return, Fear Factor Reboot, Golden Globes, And More
• Retailers Help Mitigate Risk with Oracle's AI-Driven Supply Chain Collaboration